Takhzyro

Takeda, CSL hereditary angioedema meds need steep discounts following real-world evidence review, ICER says
Fierce Pharma
Wed, 08/25/21 - 09:32 pm
Takeda
CSL
hereditary angiodema
HAE
RWE
Takhzyro
Cinryze
Haegarda
Shire's drug for rare swelling disorder wins European panel green light
Reuters
Sat, 10/20/18 - 11:04 pm
EMA
Europe
Shire
Takhzyro
HAE
Cost-effectiveness doubts could hit Shire’s Takhzyro launch
EP Vantage
Fri, 10/12/18 - 11:43 pm
Shire
Cinryze
Takhzyro
drug pricing
hereditary angiodema
FDA Approves Eight Novel Drugs in August
BioSpace
Sat, 09/1/18 - 04:17 pm
Kyowa Hakko Kirin
Poteligeo
Alnylam
Onpattro
Amicus Therapeutics
Galafold
TherapeuticMD
Annovera
Biocodex
Diacomit
Dompe Group
Oxervate
Shire
Takhzyro
Merck
Pifeltro
Shire Secures FDA Approval for HAE Drug Lanadelumab
BioSpace
Fri, 08/24/18 - 11:23 am
Shire
Takeda
HAE
hereditary angiodema
Takhzyro
lanadelumab
FDA